ARTBIO AS
Developing novel alpha radioligand therapies to redefine cancer care.
Yleiskatsaus
- 21
- Työntekijät
- 74.3milj NOK
- Liikevaihto
- 2018
- Perustettu
Kuvaus
ARTBIO is a clinical-stage radiopharmaceutical company dedicated to advancing cancer treatment through a new class of alpha radioligand therapies (ARTs). Their core mission is to develop highly effective and safe therapies by focusing on specific tumor targets combined with the optimal alpha-precurs...